Michael Nemzek joins Velocity11 of Menlo Park, Calif., as vice president of marketing, the company said this week. Nemzek previously was general manager of discovery tools at Symyx Technologies. Prior to that, Nemzek was an executive with Cellomics; Genosys Biotechnologies (now part of Sigma-Aldrich); Tropix, now part of Applied Biosystems; and EG&G, now part of PerkinElmer. Velocity11 develops automation technologies for pharma/biotech and genomics labs.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.